Fotografi av Andreas Löfberg

Andreas Löfberg

Publikationer

2026

Andreas Löfberg, Nicholas Harp, Irene Perini, Robin Kämpe, Hanna Karlsson, Michal Pietrzak, Hedy Kober, Markus Heilig (2026) The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder Neuropsychopharmacology (Artikel i tidskrift) Vidare till DOI

2025

Andreas Löfberg (2025) The role of neural biomarkers and mu-opioid receptors in social stress and addiction
Leah Mayo, Emelie Gauffin, Gavin N. Petrie, Ryann Tansey, Raegan Mary Rose Mazurka, Connor James Haggarty, Madeleine Jones, Hilda Engelbrektsson, Victoria Aminoff, Anisja Huhne-Landgraf, Mark E. Schmidt, Darrel J. Pemberton, Cecilia Fredlund, Lars Östman Vasko, Hanna Karlsson, Andreas Löfberg, Michal Pietrzak, Gerhard Andersson, Andrea Johansson Capusan, Matthew N. Hill, Markus Heilig (2025) The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial Neuropsychopharmacology, Vol. 50, s. 1564-1572 (Artikel i tidskrift) Vidare till DOI

2024

Reinoud Kaldewaij, Paula Salamone, Adam Enmalm, Lars Östman Vasko, Michal Pietrzak, Hanna Karlsson, Andreas Löfberg, Emelie Gauffin, Martin Samuelsson, Sarah Gustavson, Andrea Johansson Capusan, Håkan Olausson, Markus Heilig, Rebecca Böhme (2024) Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study Neuropsychopharmacology, Vol. 49, s. 1767-1774 (Artikel i tidskrift) Vidare till DOI
Michal Pietrzak, Adam Yngve, Paul J. Hamilton, Anna Asratian, Emelie Gauffin, Andreas Löfberg, Sarah Gustavson, Emil Persson, Andrea Johansson Capusan, Lorenzo Leggio, Irene Perini, Gustav Tinghög, Markus Heilig, Rebecca Böhme (2024) Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial Neuropsychopharmacology, Vol. 49, s. 1042-1049 (Artikel i tidskrift) Vidare till DOI

Forskning

Organisation